TNYA

NASDAQ open

Tenaya Therapeutics

0.29 USD
▼-0.01-3.85%
盘后 0.33 0.00%
2026-11-20
市值
$65.32M
市盈率
—
EPS
-0.49
股息率
—
52 周区间
0.28 – 1.46
成交量
2.97M
Beta
2.86
目标价
3.67
52W 低 0.2852W 高 1.46
价格走势

公司简介

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection ...